| Literature DB >> 1667792 |
K H Chau1, G J Dawson, I K Mushahwar, R A Gutierrez, R G Johnson, R R Lesniewski, L Mattsson, O Weiland.
Abstract
A specific IgM solid-phase enzyme-linked immunoassay for the diagnosis of a recent infection by hepatitis C virus (HCV) was developed. The assay utilizes a structural antigen encoded by sequences at the 5' end of HCV (core region) and non-structural (NS) antigens encoded by the NS-3 (33c) and NS-4 (c100-3) regions of the HCV genome. Serial serum samples from several clinically diagnosed post-transfusion non-A, non-B hepatitis patients were analyzed for anti-HCV IgM. This antibody was frequently but transiently detected. Anti-HCV core IgM was more frequently detected than anti-c100-3 or anti-33c IgM. In individuals who resolved their HCV infection or progressed to chronicity, anti-HCV IgM was produced transiently at or near the onset of clinically diagnosed acute hepatitis.Entities:
Mesh：
Substances：
Year: 1991 PMID： 1667792 DOI： 10.1016/0166-0934(91)90075-b
Source DB: PubMed Journal: J Virol Methods ISSN： 0166-0934 Impact factor: 2.014